Duopharma Biotech Berhad

Duopharma Biotech Berhad is one of Malaysia's leading pharmaceutical companies, specializing in the development, manufacturing, and marketing of generic drugs, biosimilars, and consumer healthcare products. Originally established as part of the Chemical Company of Malaysia (CCM) group, it became an independent entity and is now a major player in the ASEAN region, listed on the Main Market of Bursa Malaysia. The company is a global leader in Halal-certified pharmaceuticals and operates state-of-the-art manufacturing facilities that comply with international standards such as PIC/S. Their portfolio spans across critical therapeutic areas including oncology, renal care, cardiovascular, and diabetes. Duopharma is particularly noted for being the first Malaysian company to produce biosimilars locally, such as Erythropoietin (Erypro).